{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:09:03Z","timestamp":1793059743550,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012948","name":"Minist\u00e8re de l'Enseignement sup\u00e9rieur, de la Recherche et de l'Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.coi.2020.12.003","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T22:45:12Z","timestamp":1610405112000},"page":"15-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies"],"prefix":"10.1016","volume":"70","author":[{"given":"Delphine","family":"Leclerc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4264-6515","authenticated-orcid":false,"given":"Ananda Christina","family":"Staats Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles J","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gilot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2020.12.003_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0009-2797(02)00070-4","article-title":"Aryl hydrocarbon receptors: diversity and evolution","volume":"141","author":"Hahn","year":"2002","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.coi.2020.12.003_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0742-8413(98)10028-2","article-title":"The aryl hydrocarbon receptor: a comparative perspective","volume":"121","author":"Hahn","year":"1998","journal-title":"Comp Biochem Physiol C Pharmacol Toxicol Endocrinol"},{"key":"10.1016\/j.coi.2020.12.003_bib0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pharmtox.43.100901.135828","article-title":"Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals","volume":"43","author":"Denison","year":"2003","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0020","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186654","article-title":"Aryl hydrocarbon receptor (AHR) ligands as selective AHR modulators (SAhRMs)","volume":"21","author":"Safe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2020.12.003_bib0025","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/brain\/awz098","article-title":"Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmus","volume":"142","author":"Mayer","year":"2019","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.coi.2020.12.003_bib0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.coi.2020.12.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114093","article-title":"Aryl hydrocarbon receptor (AHR) functions: balancing opposing processes including inflammatory reactions","volume":"178","author":"Bock","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coi.2020.12.003_bib0040","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Ah receptor ligands in cancer: friend and foe","volume":"14","author":"Murray","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.coi.2020.12.003_bib0045","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1124\/dmd.115.064246","article-title":"Indole and tryptophan metabolism: endogenous and dietary routes to Ah receptor activation","volume":"43","author":"Hubbard","year":"2015","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/nu12092846","article-title":"Nutritional therapy to modulate tryptophan metabolism and aryl hydrocarbon-receptor signaling activation in human diseases","volume":"12","author":"Ghiboub","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.coi.2020.12.003_bib0055","doi-asserted-by":"crossref","first-page":"17767","DOI":"10.1074\/jbc.M209594200","article-title":"Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor","volume":"278","author":"Bunger","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/taap.1996.0210","article-title":"Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity","volume":"140","author":"Fernandez-Salguero","year":"1996","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.coi.2020.12.003_bib0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1046\/j.1365-2443.1997.1490345.x","article-title":"Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor","volume":"2","author":"Mimura","year":"1997","journal-title":"Genes Cells Devoted Mol Cell Mech"},{"key":"10.1016\/j.coi.2020.12.003_bib0070","article-title":"Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects","volume":"10","author":"Badawy","year":"2017","journal-title":"Int J Tryptophan Res IJTR"},{"key":"10.1016\/j.coi.2020.12.003_sbref0075","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.cell.2020.07.038","article-title":"IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression","volume":"182","author":"Sadik","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2020.12.003_bib0080","first-page":"1194","article-title":"The aryl hydrocarbon receptor: studies using the AHR-null mice","volume":"26","author":"Gonzalez","year":"1998","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfr218","article-title":"Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor","volume":"124","author":"Denison","year":"2011","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_bib0090","article-title":"Ligand activation of the Ah receptor contributes to gastrointestinal homeostasis","volume":"2","author":"Murray","year":"2017","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_bib0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.15252\/embj.201695027","article-title":"Aryl hydrocarbon receptor is required for optimal B-cell proliferation","volume":"36","author":"Villa","year":"2017","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2020.12.003_bib0100","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.febslet.2007.03.046","article-title":"The aryl hydrocarbon receptor, more than a xenobiotic-interacting protein","volume":"581","author":"Barouki","year":"2007","journal-title":"FEBS Lett"},{"key":"10.1016\/j.coi.2020.12.003_bib0105","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/mol.105.018705","article-title":"Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries","volume":"69","author":"Tijet","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coi.2020.12.003_bib0110","doi-asserted-by":"crossref","first-page":"12841","DOI":"10.1021\/bi00210a037","article-title":"Binding of transformed Ah receptor complex to a dioxin responsive transcriptional enhancer: evidence for two distinct heteromeric DNA-binding forms","volume":"32","author":"Swanson","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.coi.2020.12.003_bib0115","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1093\/nar\/gkh782","article-title":"Comparative analysis of dioxin response elements in human, mouse and rat genomic sequences","volume":"32","author":"Sun","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0120","doi-asserted-by":"crossref","first-page":"28708","DOI":"10.1074\/jbc.274.40.28708","article-title":"Aryl hydrocarbon receptor imported into the nucleus following ligand binding is rapidly degraded via the cytosplasmic proteasome following nuclear export","volume":"274","author":"Davarinos","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/S0009-2797(02)00065-0","article-title":"The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation","volume":"141","author":"Pollenz","year":"2002","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.coi.2020.12.003_bib0130","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1021\/tx900241g","article-title":"1-Nitropyrene stabilizes the mRNA of cytochrome P450 1a1, a carcinogen-metabolizing enzyme, via the Akt pathway","volume":"22","author":"Chu","year":"2009","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_bib0135","doi-asserted-by":"crossref","DOI":"10.1016\/0041-008X(84)90054-1","article-title":"Studies on the metabolic fate of [14C]2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouse","volume":"73","author":"Koshakji","year":"1984","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.coi.2020.12.003_bib0140","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0041-008X(76)90001-6","article-title":"The fate of 2,3,7,8-tetrachlorodibenzo-p-dioxin following single and repeated oral doses to the rat","volume":"36","author":"Rose","year":"1976","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.coi.2020.12.003_bib0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/BF01055015","article-title":"Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding","volume":"18","author":"Phillips","year":"1989","journal-title":"Arch Environ Contam Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_bib0150","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1073\/pnas.1118467109","article-title":"Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor","volume":"109","author":"Wincent","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2020.12.003_bib0155","first-page":"1","article-title":"Kynurenine pathway metabolites in humans: disease and healthy States","volume":"2","author":"Chen","year":"2009","journal-title":"Int J Tryptophan Res IJTR"},{"key":"10.1016\/j.coi.2020.12.003_bib0160","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1158\/1055-9965.EPI-13-0770","article-title":"Circulating biomarkers of tryptophan and the kynurenine pathway and lung cancer risk","volume":"23","author":"Chuang","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.coi.2020.12.003_bib0165","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1101\/gad.327056.119","article-title":"MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer","volume":"33","author":"Venkateswaran","year":"2019","journal-title":"Genes Dev"},{"key":"10.1016\/j.coi.2020.12.003_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0112945","article-title":"Involvement of the kynurenine pathway in human glioma pathophysiology","volume":"9","author":"Adams","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2020.12.003_bib0175","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/s41598-019-48635-x","article-title":"Exhaustion of CD4+ T-cells mediated by the kynurenine pathway in melanoma","volume":"9","author":"Rad Pour","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2020.12.003_bib0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbr.2016.06.018","article-title":"Deletion of TDO2, IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function","volume":"312","author":"Too","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01801","article-title":"Limitations and off-target effects of tryptophan-related IDO inhibitors in cancer treatment","volume":"10","author":"G\u00fcnther","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2020.12.003_bib0190","first-page":"108","article-title":"Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis","volume":"5","author":"Guillemin","year":"2000","journal-title":"Redox Rep Commun Free Radic Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19123851","article-title":"The role of the aryl hydrocarbon receptor (AHR) in immune and inflammatory diseases","volume":"19","author":"Neavin","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2020.12.003_bib0200","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3390\/ijms21061983","article-title":"Aryl hydrocarbon receptor in post-mortem hippocampus and in serum from young, elder, and Alzheimer\u2019s patients","volume":"21","author":"Ramos-Garc\u00eda","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coi.2020.12.003_bib0205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2004.06.177","article-title":"Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting","volume":"321","author":"Boutros","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coi.2020.12.003_sbref0210","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06951-2","article-title":"Sustained activation of the aryl hydrocarbon receptor transcription factor promotes resistance to BRAF-inhibitors in melanoma","volume":"9","author":"Corre","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2020.12.003_bib0215","doi-asserted-by":"crossref","first-page":"12310","DOI":"10.1074\/jbc.271.21.12310","article-title":"Cooperative interaction between AhR.Arnt and Sp1 for the drug-inducible expression of CYP1A1 gene","volume":"271","author":"Kobayashi","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0220","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/nar\/26.12.3044","article-title":"Functional and physical interactions between the estrogen receptor Sp1 and nuclear aryl hydrocarbon receptor complexes","volume":"26","author":"Wang","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0225","doi-asserted-by":"crossref","first-page":"11490","DOI":"10.1021\/bi982578f","article-title":"Regulation of constitutive gene expression through interactions of Sp1 protein with the nuclear aryl hydrocarbon receptor complex","volume":"38","author":"Wang","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.coi.2020.12.003_bib0230","first-page":"1470","article-title":"A novel cis-acting DNA element required for a high level of inducible expression of the rat P-450c gene","volume":"10","author":"Yanagida","year":"1990","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coi.2020.12.003_bib0235","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1210\/me.2007-0211","article-title":"RelB, a new partner of aryl hydrocarbon receptor-mediated transcription","volume":"21","author":"Vogel","year":"2007","journal-title":"Mol Endocrinol Baltim Md"},{"key":"10.1016\/j.coi.2020.12.003_bib0240","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1074\/jbc.275.4.2943","article-title":"Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest","volume":"275","author":"Puga","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0245","doi-asserted-by":"crossref","first-page":"5498","DOI":"10.1038\/sj.onc.1203945","article-title":"The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells","volume":"19","author":"Kim","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.coi.2020.12.003_bib0250","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1074\/jbc.274.1.510","article-title":"Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity","volume":"274","author":"Tian","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2020.12.003_bib0255","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1006\/abbi.1999.1552","article-title":"The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRalpha1","volume":"373","author":"Klinge","year":"2000","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.coi.2020.12.003_bib0260","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/nature01606","article-title":"Modulation of oestrogen receptor signalling by association with the activated dioxin receptor","volume":"423","author":"Ohtake","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.coi.2020.12.003_bib0265","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1073\/pnas.0708366105","article-title":"Genome-wide B1 retrotransposon binds the transcription factors dioxin receptor and Slug and regulates gene expression in vivo","volume":"105","author":"Roman","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2020.12.003_bib0270","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2020.12.003_bib0275","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ni.1915","article-title":"Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell\u2013like and Foxp3+ regulatory T cells","volume":"11","author":"Gandhi","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2020.12.003_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2007.04.111","article-title":"AhR- and c-maf-dependent induction of beta7-integrin expression in human macrophages in response to environmental polycyclic aromatic hydrocarbons","volume":"358","author":"Monteiro","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coi.2020.12.003_bib0285","first-page":"797","article-title":"Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells","volume":"183","author":"Pot","year":"2009","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.coi.2020.12.003_bib0290","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1161\/CIRCRESAHA.108.176990","article-title":"Aryl hydrocarbon receptor is activated by glucose and regulates the thrombospondin-1 gene promoter in endothelial cells","volume":"102","author":"Dabir","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0295","doi-asserted-by":"crossref","first-page":"9721","DOI":"10.1073\/pnas.0804231105","article-title":"Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells","volume":"105","author":"Kimura","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2020.12.003_bib0300","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1084\/jem.20090560","article-title":"Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses","volume":"206","author":"Kimura","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2020.12.003_bib0305","article-title":"In vivo induction of Tr1 cells via mucosal dendritic cells and AHR signaling","volume":"6","author":"Wu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.coi.2020.12.003_bib0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.smim.2011.07.005","article-title":"Type 1 regulatory T cells (Tr1) in autoimmunity","volume":"23","author":"Pot","year":"2011","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2020.12.003_bib0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20081438","article-title":"Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells","volume":"206","author":"Veldhoen","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2020.12.003_bib0320","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-3139-2_16","article-title":"The aryl hydrocarbon receptor in immunity: tools and potential","volume":"1371","author":"Esser","year":"2016","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"10.1016\/j.coi.2020.12.003_bib0325","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2020.12.003_bib0330","article-title":"Gain-of-function CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and therapy-resistance","author":"Gautron","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2020.12.003_bib0335","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.coi.2020.12.003_bib0340","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noz195","article-title":"Driving mesenchymal transition in glioblastoma","volume":"22","author":"Platten","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0345","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2018.06.025","article-title":"Toward minimal residual disease-directed therapy in melanoma","volume":"174","author":"Rambow","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.coi.2020.12.003_sbref0350","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","article-title":"Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress","volume":"33","author":"Tsoi","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coi.2020.12.003_sbref0355","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41556-020-0547-3","article-title":"Robust gene expression programs underlie recurrent cell states and phenotype switching in melanoma","volume":"22","author":"Wouters","year":"2020","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0360","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2020.07.003","article-title":"Memory sequencing reveals heritable single-cell gene expression programs associated with distinct cellular behaviors","volume":"182","author":"Shaffer","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2020.12.003_bib0365","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1208900","article-title":"Stable overexpression of Smad7 in human melanoma cells inhibits their tumorigenicity in vitro and in vivo","volume":"24","author":"Javelaud","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.coi.2020.12.003_sbref0370","article-title":"Transcriptional downregulation of MHC class I and melanoma de-differentiation in resistance to PD-1 inhibition","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2020.12.003_bib0375","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2020.12.003_bib0380","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1093\/nar\/gkw095","article-title":"Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor","volume":"44","author":"Morales-Hern\u00e1ndez","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2020.12.003_bib0385","article-title":"Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-\u03b3-induced immunologic dormancy of tumor-repopulating cells","volume":"8","author":"Liu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2020.12.003_sbref0390","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ccell.2018.02.005","article-title":"Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation","volume":"33","author":"Liu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.coi.2020.12.003_bib0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050257","article-title":"Nanosensor detection of an immunoregulatory tryptophan influx\/kynurenine efflux cycle","volume":"5","author":"Kaper","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.coi.2020.12.003_bib0400","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature10491","article-title":"An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor","volume":"478","author":"Opitz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coi.2020.12.003_bib0405","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1774298","article-title":"Trial watch: the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy","volume":"9","author":"Daill\u00e8re","year":"2020","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.coi.2020.12.003_bib0410","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.coi.2020.12.003_bib0415","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1021\/tx300169e","article-title":"Quercetin, resveratrol, and curcumin are indirect activators of the aryl hydrocarbon receptor (AHR)","volume":"25","author":"Mohammadi-Bardbori","year":"2012","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.coi.2020.12.003_bib0420","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2020.12.003_bib0425","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.562812","article-title":"The gut microbiota, kynurenine pathway, and immune system interaction in the development of brain cancer","volume":"8","author":"Dehhaghi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0430","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nbt.4180","article-title":"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.coi.2020.12.003_bib0435","doi-asserted-by":"crossref","DOI":"10.1038\/nature13323","article-title":"Aryl hydrocarbon receptor control of a disease tolerance defence pathway","volume":"511","author":"Bessede","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coi.2020.12.003_bib0440","article-title":"IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis","volume":"185","author":"Yan","year":"2010","journal-title":"J Immunol Baltim Md 1950"},{"key":"10.1016\/j.coi.2020.12.003_bib0445","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1014465107","article-title":"Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism","volume":"107","author":"Nguyen","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coi.2020.12.003_sbref0450","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2020.12.003_bib0455","article-title":"Targeting the IDO1-kynurenine-AhR pathway for cancer immunotherapy","volume":"39","author":"Pinto","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coi.2020.12.003_bib0460","series-title":"The Aryl Hydrocarbon Receptor (AHR) as a Driver of Cancer Immunosuppression","author":"Kenison-White","year":"2018"},{"key":"10.1016\/j.coi.2020.12.003_bib0465","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2016.00045","article-title":"New trends in aryl hydrocarbon receptor biology","volume":"4","author":"Mulero-Navarro","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0470","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41416-019-0664-6","article-title":"The therapeutic potential of targeting tryptophan catabolism in cancer","volume":"122","author":"Opitz","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coi.2020.12.003_bib0475","doi-asserted-by":"crossref","DOI":"10.1158\/1535-7163.715.3.6","article-title":"Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells","volume":"3","author":"Loaiza-P\u00e9rez","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.coi.2020.12.003_bib0480","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1002\/jcb.26114","article-title":"In vitro antitumor effects of AHR ligands aminoflavone (AFP 464) and benzothiazole (5F 203) in human renal carcinoma cells","volume":"118","author":"Luzzani","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.coi.2020.12.003_bib0485","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nature17161","article-title":"Melanoma addiction to the long non-coding RNA SAMMSON","volume":"531","author":"Leucci","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.coi.2020.12.003_bib0490","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/ncb3623","article-title":"A non-coding function of TYRP1 mRNA promotes melanoma growth","volume":"19","author":"Gilot","year":"2017","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.coi.2020.12.003_bib0495","doi-asserted-by":"crossref","DOI":"10.1021\/acs.est.5b02906","article-title":"Development of species-specific ah receptor-responsive third generation CALUX cell lines with enhanced responsiveness and improved detection limits","volume":"49","author":"Brennan","year":"2015","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.coi.2020.12.003_sbref0500","article-title":"Development of a novel recombinant cell line for detection and characterization of Ah receptor nuclear translocation in intact cells","volume":"66","author":"Hayashi","year":"2020","journal-title":"Toxicol Vitro Int J Publ Assoc BIBRA"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791520301473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791520301473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:40:44Z","timestamp":1760604044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791520301473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":100,"alternative-id":["S0952791520301473"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2020.12.003","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detrimental activation of AhR pathway in cancer: an overview of therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2020.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}